NFKB1 and brain disorder: In summary, TMP, an alkaloid derived from Ligusticum chuanxiong, attenuates neuroinflammatory responses in vitro and in vivo, possibly via activating SIRT1 and suppressing NF-κB pathway (Figure 8), thus indicating TMP might act as therapeutic agent for the treatment of neuroinflammation and associated brain disorders.